Prostate Cancer - Results from #100

Prediagnostic Plasma Nutrimetabolomics and Prostate Cancer Risk: A Nested Case-Control Analysis Within the EPIC Study. December 18, 2024

Administration and cancer-control outcomes of bone-modifying agents in real-world patients with metastatic castration-resistant prostate cancer. December 18, 2024

A Pilot Study of PSMA PET/CT and MRI Fusion for Prostate Cancer: Software to Replace PET/MRI Hardware. December 18, 2024

The Challenge of External Generalisability: Insights from the Bicentric Validation of a [68Ga]Ga-PSMA-11 PET Based Radiomics Signature for Primary Prostate Cancer Characterisation Using Histopathology as Reference. December 18, 2024

Improved prognosis of de novo metastatic prostate cancer after an introduction of life-prolonging agents for castration-resistant prostate cancer. December 18, 2024

Genitourinary Cancer Care in Low- and Middle-Income Countries: Disparities in Incidence and Access to Care December 17, 2024

Patient preferences for life expectancy cutoffs for aggressive treatment in clinically localized prostate cancer. December 17, 2024

Five-year outcomes of moderately hypofractionated proton therapy incorporating elective pelvic nodal irradiation for high-risk prostate cancer. December 17, 2024

High Omega-3, Low Omega-6 Diet With Fish Oil for Men With Prostate Cancer on Active Surveillance: The CAPFISH-3 Randomized Clinical Trial. December 17, 2024

Oncological Safety of MRI-Informed Biopsy Decision-Making in Men With Suspected Prostate Cancer. December 17, 2024

Canonical androgen response element motifs are tumor suppressive regulatory elements in the prostate. December 17, 2024

Prostate-specific antigen kinetics in Asian patients with metastatic castration-sensitive prostate cancer treated with apalutamide in the TITAN trial: A post hoc analysis. December 17, 2024

Preoperative detection of extraprostatic tumor extension in patients with primary prostate cancer utilizing [68Ga]Ga-PSMA-11 PET/MRI. December 16, 2024

Polygenic Risk Score and Upgrading in Patients With Prostate Cancer Receiving Active Surveillance. December 16, 2024

Digital Pathology-based Artificial Intelligence Biomarker Validation in Metastatic Prostate Cancer. December 16, 2024

Prognostic value of baseline alkaline phosphatase of 177Lu-PSMA radioligand therapy in metastatic castration-resistant prostate cancer: A systematic review and meta-analysis. December 16, 2024

Recent Patterns and Trends in Global Prostate Cancer Incidence and Mortality: An Update. December 16, 2024

Assessing the Molecular Heterogeneity of Prostate Cancer Biopsy Sampling: Insights from the MAST Trial. December 16, 2024

Castrate-resistant prostate cancer response to taxane is determined by an HNF1-dependent apoptosis resistance circuit. December 13, 2024

Stress testing deep learning models for prostate cancer detection on biopsies and surgical specimens. December 13, 2024

Page 6 of 1451